{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:51:43Z","timestamp":1761807103640},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,7,14]],"date-time":"2004-07-14T00:00:00Z","timestamp":1089763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s10067-004-0959-7","type":"journal-article","created":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T10:49:11Z","timestamp":1089715751000},"page":"18-21","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy of intravenous immunoglobulin in chronic idiopathic pericarditis: report of four cases"],"prefix":"10.1007","volume":"24","author":[{"given":"D.","family":"Peterlana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Simeoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Corrocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,14]]},"reference":[{"key":"959_CR1","unstructured":"Spodick DH (1992) Disease of the pericardium. In: Pamley WW, Chatterjee K (eds) Cardiology. Lippincott, Philadelphia, pp 1\u201334"},{"key":"959_CR2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0248-8663(01)00492-1","volume":"22","author":"Granel","year":"2001","unstructured":"Granel B, Serratrice J, Rey J, Pache X, et al. (2001) Is chronic or recurrent idiopathic an autonomous inflammatory disease? Rev Med Interne 22:1204\u20131212","journal-title":"Rev Med Interne"},{"key":"959_CR3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/PL00001993","volume":"25","author":"Pankuweit","year":"2000","unstructured":"Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25:748\u2013754","journal-title":"Herz"},{"key":"959_CR4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","volume":"6","author":"Lunardi","year":"2000","unstructured":"Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A (2000) Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183\u20131186","journal-title":"Nat Med"},{"key":"959_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1471-4906(02)00007-8","volume":"24","author":"Shoenfeld","year":"2003","unstructured":"Shoenfeld Y (2003) Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unravelled. Trends Immunol 24:2\u20134","journal-title":"Trends Immunol"},{"key":"959_CR6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/eurheartj\/15.suppl_2.120","volume":"15","author":"Millaire","year":"1994","unstructured":"Millaire A, de Groote P, Decoulx E, Goullard L, Ducloux G (1994) Treatment of recurrent pericarditis with colchicine. Eur Heart J 15:120\u2013124","journal-title":"Eur Heart J"},{"key":"959_CR7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0735-1097(03)00778-2","volume":"42","author":"Raatikka","year":"2003","unstructured":"Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV (2003) Recurrent pericarditis in children and adolescents: report of 15 cases. J Am Coll Cardiol 42:759\u2013764","journal-title":"J Am Coll Cardiol"},{"key":"959_CR8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"Bruton","year":"1952","unstructured":"Bruton OC (1952) Agammaglobulinemias. Pediatrics 9:722\u2013728","journal-title":"Pediatrics"},{"key":"959_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","volume":"325","author":"Buckley","year":"1991","unstructured":"Buckley RH, Shiff RI (1991) The use of intravenous immune globulin in immunodeficiency disease. N Engl J Med 325:110\u2013117","journal-title":"N Engl J Med"},{"key":"959_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00918189","volume":"10","author":"Schwartz","year":"1990","unstructured":"Schwartz SA (1990) Intravenous immunoglobulin for autoimmune disorders. J Clin Immunol 10:81\u201389","journal-title":"J Clin Immunol"},{"key":"959_CR11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/41.4.367","volume":"41","author":"Pyne","year":"2002","unstructured":"Pyne D, Ehrestein M, Morris V (2002) The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology 41:367\u2013374","journal-title":"Rheumatology"},{"key":"959_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00063030-200216010-00005","volume":"16","author":"Larroche","year":"2002","unstructured":"Larroche C, Chanseaud Y, Garcia de la Pena-Lefebvre P, Mouthon L (2002) Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders. BioDrugs 16:47\u201355","journal-title":"BioDrugs"},{"key":"959_CR13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-6749(97)70217-3","volume":"100","author":"Ballow","year":"1997","unstructured":"Ballow M (1997) Mechanism of action of intravenous immune serum globulin in autoimmune and inflammatory disease. J Allergy Clin Immunol 100:151\u2013157","journal-title":"J Allergy Clin Immunol"},{"key":"959_CR14","first-page":"227","volume":"40","author":"Zhiya","year":"1993","unstructured":"Zhiya Yu, Lennon VA (1993) Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 40:227\u2013228","journal-title":"N Engl J Med"},{"key":"959_CR15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"Kazatchkine","year":"2001","unstructured":"Kazatchkine MD, Kaveri SV (2001) Immunomodulation of the autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"959_CR16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","volume":"291","author":"Samuelsson","year":"2001","unstructured":"Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484\u2013486","journal-title":"Science"},{"key":"959_CR17","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1067\/mai.2001.118640","volume":"108","author":"Sacher","year":"2001","unstructured":"Sacher RA, IVIG Advisory Panel (2001) Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 108:S139\u2013S146","journal-title":"J Allergy Clin Immunol"},{"key":"959_CR18","first-page":"64","volume":"4","author":"Tona","year":"2003","unstructured":"Tona F, Bellotto F, Laveder F, Meneghin A, Sinagra GF, Marcolongo R (2003) Efficacy of high-dose intravenous immunoglobulins in two patients with idiopathic recurrent pericarditis refractory to previous immunosuppressive treatment. Ital Heart J 4:64\u201368","journal-title":"Ital Heart J"},{"key":"959_CR19","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.CIR.97.21.2183","volume":"97","author":"Adler","year":"1998","unstructured":"Adler Y, Guindo J, Rodriguez de la Serna A, et al. (1998) Colchicine treatment for recurrent pericarditis. Circulation 97:2183\u20132285","journal-title":"Circulation"},{"key":"959_CR20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0733-8651(18)30334-5","volume":"8","author":"Fowler","year":"1990","unstructured":"Fowler NO (1990) Recurrent pericarditis. Cardiol Clin 8:621\u2013626","journal-title":"Cardiol Clin"},{"key":"959_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/000992289603500105","volume":"35","author":"Ryan","year":"1996","unstructured":"Ryan ME, Webster ML, Statler JD (1996) Adverse effects of intravenous immunoglobulin therapy. Clin Pediatr 35:23\u201331","journal-title":"Clin Pediatr"},{"key":"959_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","volume":"12","author":"Krause","year":"2002","unstructured":"Krause I, Wu R, Sherer Y, et al. (2002) In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations\u2014a potential role for adjuvant intravenous immunoglobulin therapy in infectious disease. Transfus Med 12:133\u2013139","journal-title":"Transfus Med"},{"key":"959_CR23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1253\/jcj.62.871","volume":"62","author":"Takeda","year":"1998","unstructured":"Takeda Y, Yasuda S, Miyazaki S, Daikoku S, Nakatani S, Nonogi H (1998) High-dose immunoglobulin G therapy for fulminant myocarditis. Jpn Circ J 62:871\u2013872","journal-title":"Jpn Circ J"},{"key":"959_CR24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/clc.4960211106","volume":"21","author":"Portugese","year":"1998","unstructured":"Portugese S, Amital H, Tenenbaum A, et al. (1998) Clinical characteristics of ruptured chordae tendineae in hospitalized patients: primary tear versus infective endocarditis. Clin Cardiol 21:813\u2013816","journal-title":"Clin Cardiol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-0959-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-004-0959-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-004-0959-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T21:28:07Z","timestamp":1705181287000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-004-0959-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,14]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s10067-004-0959-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,14]]}}}